Our preliminary analyses indicated that methylation-induced galanin receptor type 1 (GALR1) gene silencing is a critical event in HNSCC progression and that restoring expression inhibits tumor cell growth [11]. This evidence concerns the gene GALR1 and head and neck squamous cell carcinoma.